High Phobic Anxiety Linked to Relative Telomere Length

Share this article:
High Phobic Anxiety Linked to Relative Telomere Length
High Phobic Anxiety Linked to Relative Telomere Length

(HealthDay News) – Older women who have phobic anxiety have shorter relative telomere lengths.

Olivia I Okereke, MD, from Brigham and Women's Hospital in Boston, and colleagues measured relative telomere lengths in peripheral blood leukocytes from 5,243 nurses (42–69 years old) who had completed the Crown-Crisp index, which measures symptoms of phobic anxiety.

The researchers found that women with higher phobic anxiety generally had shorter relative telomere lengths, even after adjusting for possible confounders, including smoking and physical activity. For the most phobic women (Crown-Crisp index of >6) the difference in relative telomere length was comparable to that of a woman six years older. The association was stronger in women who were overweight, had never smoked, and had been born to fathers who were >40 years.

"In summary, high phobic anxiety may be associated with shorter leukocyte relative telomere lengths in middle-aged and older women," Okereke and colleagues conclude. "Identification of these novel associations invites further investigation in large-scale prospective studies, with detailed ascertainment of anxiety and other mental health variables and repeated measures of telomere length."

Abstract
Full Text (subscription or payment may be required)

Share this article:
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs